Self-reported anxiety, depressive, and vasomotor symptoms: A study of perimenopausal women presenting to a specialized midlife assessment center

Andreea L. Seritan, Ana-Maria Iosif, Ju Hui Park, Deborah Deatheragehand, Richard L Sweet, Ellen B Gold

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Objective: The aim of this study was to examine the association of vasomotor symptoms (VMS) with anxiety and/or depressive symptoms in perimenopausal women. Methods: A retrospective chart review of 487 women 40 to 64 years old seen during October 2004 to December 2006 in the Women's Midlife Assessment Program at the University of California, Davis, was performed. Of these, 395 women were included in the analysis: 58 (15%) were premenopausal, 199 (50%) were perimenopausal, and 138 (35%) were postmenopausal. VMS bothersomeness was represented by converting Likert-scale ratings for hot flashes and night sweats to scores and adding them into an overall score. Multiple logistic regression models were used to quantify the association of self-reported anxiety and/or depressive symptoms with VMS bothersomeness. Results: Thirty-one (53%) premenopausal, 131 (66%) perimenopausal, and 69 (50%) postmenopausal women reported anxiety and/or depressive symptoms. Perimenopausal and postmenopausal women reporting anxiety and/or depressive symptoms had significantly higher VMS bothersomeness scores (2.2 ± 1.7 and 2.2 ± 1.9, respectively) than did women who did not report these symptoms (1.7 ± 1.7 and 1.6 ± 1.7, respectively; both P values < 0.05). Women experiencing more bothersome VMS were significantly more likely to report anxiety and/or depressive symptoms (odds ratio, 1.5; P < 0.01). Perimenopausal women were significantly more likely to report anxiety and/or depressive symptoms than were postmenopausal women (odds ratio, 1.9; P < 0.01). Both associations remained significant after restricting the analyses to women not taking hormone therapy or psychotropics. Conclusions: VMS bothersomeness was associated with self-reported anxiety and/or depressive symptoms, showing the importance of screening for anxiety and mood changes during perimenopause.

Original languageEnglish (US)
Pages (from-to)410-415
Number of pages6
JournalMenopause
Volume17
Issue number2
DOIs
StatePublished - Mar 2010

Fingerprint

Anxiety
Depression
Logistic Models
Odds Ratio
Perimenopause
Hot Flashes
Sweat
Hormones

Keywords

  • Anxiety
  • Depressive symptoms
  • Perimenopause
  • Vasomotor symptoms

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Self-reported anxiety, depressive, and vasomotor symptoms : A study of perimenopausal women presenting to a specialized midlife assessment center. / Seritan, Andreea L.; Iosif, Ana-Maria; Park, Ju Hui; Deatheragehand, Deborah; Sweet, Richard L; Gold, Ellen B.

In: Menopause, Vol. 17, No. 2, 03.2010, p. 410-415.

Research output: Contribution to journalArticle

@article{18f559e4488540818fbe8edf25f6df24,
title = "Self-reported anxiety, depressive, and vasomotor symptoms: A study of perimenopausal women presenting to a specialized midlife assessment center",
abstract = "Objective: The aim of this study was to examine the association of vasomotor symptoms (VMS) with anxiety and/or depressive symptoms in perimenopausal women. Methods: A retrospective chart review of 487 women 40 to 64 years old seen during October 2004 to December 2006 in the Women's Midlife Assessment Program at the University of California, Davis, was performed. Of these, 395 women were included in the analysis: 58 (15{\%}) were premenopausal, 199 (50{\%}) were perimenopausal, and 138 (35{\%}) were postmenopausal. VMS bothersomeness was represented by converting Likert-scale ratings for hot flashes and night sweats to scores and adding them into an overall score. Multiple logistic regression models were used to quantify the association of self-reported anxiety and/or depressive symptoms with VMS bothersomeness. Results: Thirty-one (53{\%}) premenopausal, 131 (66{\%}) perimenopausal, and 69 (50{\%}) postmenopausal women reported anxiety and/or depressive symptoms. Perimenopausal and postmenopausal women reporting anxiety and/or depressive symptoms had significantly higher VMS bothersomeness scores (2.2 ± 1.7 and 2.2 ± 1.9, respectively) than did women who did not report these symptoms (1.7 ± 1.7 and 1.6 ± 1.7, respectively; both P values < 0.05). Women experiencing more bothersome VMS were significantly more likely to report anxiety and/or depressive symptoms (odds ratio, 1.5; P < 0.01). Perimenopausal women were significantly more likely to report anxiety and/or depressive symptoms than were postmenopausal women (odds ratio, 1.9; P < 0.01). Both associations remained significant after restricting the analyses to women not taking hormone therapy or psychotropics. Conclusions: VMS bothersomeness was associated with self-reported anxiety and/or depressive symptoms, showing the importance of screening for anxiety and mood changes during perimenopause.",
keywords = "Anxiety, Depressive symptoms, Perimenopause, Vasomotor symptoms",
author = "Seritan, {Andreea L.} and Ana-Maria Iosif and Park, {Ju Hui} and Deborah Deatheragehand and Sweet, {Richard L} and Gold, {Ellen B}",
year = "2010",
month = "3",
doi = "10.1097/gme.0b013e3181bf5a62",
language = "English (US)",
volume = "17",
pages = "410--415",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Self-reported anxiety, depressive, and vasomotor symptoms

T2 - A study of perimenopausal women presenting to a specialized midlife assessment center

AU - Seritan, Andreea L.

AU - Iosif, Ana-Maria

AU - Park, Ju Hui

AU - Deatheragehand, Deborah

AU - Sweet, Richard L

AU - Gold, Ellen B

PY - 2010/3

Y1 - 2010/3

N2 - Objective: The aim of this study was to examine the association of vasomotor symptoms (VMS) with anxiety and/or depressive symptoms in perimenopausal women. Methods: A retrospective chart review of 487 women 40 to 64 years old seen during October 2004 to December 2006 in the Women's Midlife Assessment Program at the University of California, Davis, was performed. Of these, 395 women were included in the analysis: 58 (15%) were premenopausal, 199 (50%) were perimenopausal, and 138 (35%) were postmenopausal. VMS bothersomeness was represented by converting Likert-scale ratings for hot flashes and night sweats to scores and adding them into an overall score. Multiple logistic regression models were used to quantify the association of self-reported anxiety and/or depressive symptoms with VMS bothersomeness. Results: Thirty-one (53%) premenopausal, 131 (66%) perimenopausal, and 69 (50%) postmenopausal women reported anxiety and/or depressive symptoms. Perimenopausal and postmenopausal women reporting anxiety and/or depressive symptoms had significantly higher VMS bothersomeness scores (2.2 ± 1.7 and 2.2 ± 1.9, respectively) than did women who did not report these symptoms (1.7 ± 1.7 and 1.6 ± 1.7, respectively; both P values < 0.05). Women experiencing more bothersome VMS were significantly more likely to report anxiety and/or depressive symptoms (odds ratio, 1.5; P < 0.01). Perimenopausal women were significantly more likely to report anxiety and/or depressive symptoms than were postmenopausal women (odds ratio, 1.9; P < 0.01). Both associations remained significant after restricting the analyses to women not taking hormone therapy or psychotropics. Conclusions: VMS bothersomeness was associated with self-reported anxiety and/or depressive symptoms, showing the importance of screening for anxiety and mood changes during perimenopause.

AB - Objective: The aim of this study was to examine the association of vasomotor symptoms (VMS) with anxiety and/or depressive symptoms in perimenopausal women. Methods: A retrospective chart review of 487 women 40 to 64 years old seen during October 2004 to December 2006 in the Women's Midlife Assessment Program at the University of California, Davis, was performed. Of these, 395 women were included in the analysis: 58 (15%) were premenopausal, 199 (50%) were perimenopausal, and 138 (35%) were postmenopausal. VMS bothersomeness was represented by converting Likert-scale ratings for hot flashes and night sweats to scores and adding them into an overall score. Multiple logistic regression models were used to quantify the association of self-reported anxiety and/or depressive symptoms with VMS bothersomeness. Results: Thirty-one (53%) premenopausal, 131 (66%) perimenopausal, and 69 (50%) postmenopausal women reported anxiety and/or depressive symptoms. Perimenopausal and postmenopausal women reporting anxiety and/or depressive symptoms had significantly higher VMS bothersomeness scores (2.2 ± 1.7 and 2.2 ± 1.9, respectively) than did women who did not report these symptoms (1.7 ± 1.7 and 1.6 ± 1.7, respectively; both P values < 0.05). Women experiencing more bothersome VMS were significantly more likely to report anxiety and/or depressive symptoms (odds ratio, 1.5; P < 0.01). Perimenopausal women were significantly more likely to report anxiety and/or depressive symptoms than were postmenopausal women (odds ratio, 1.9; P < 0.01). Both associations remained significant after restricting the analyses to women not taking hormone therapy or psychotropics. Conclusions: VMS bothersomeness was associated with self-reported anxiety and/or depressive symptoms, showing the importance of screening for anxiety and mood changes during perimenopause.

KW - Anxiety

KW - Depressive symptoms

KW - Perimenopause

KW - Vasomotor symptoms

UR - http://www.scopus.com/inward/record.url?scp=77949345156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949345156&partnerID=8YFLogxK

U2 - 10.1097/gme.0b013e3181bf5a62

DO - 10.1097/gme.0b013e3181bf5a62

M3 - Article

C2 - 20216277

AN - SCOPUS:77949345156

VL - 17

SP - 410

EP - 415

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 2

ER -